Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 2/20 | 0.50 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.50 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.50 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.50 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.50 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL8104984 | 0.98 | HDAC3 (0.48) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| Acetic Acid SCHEMBL10620271 | 0.94 | HDAC3 (0.46) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL1838985 | 0.94 | HDAC3 (0.50) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL13327139 | 0.92 | HDAC3 (0.53) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL2963290 | 0.92 | HDAC3 (0.53) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL10845864 | 0.92 | HDAC3 (0.48) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL15132444 | 0.92 | HDAC3 (0.53) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL20859564 | 0.92 | HDAC3 (0.53) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL11207545 | 0.92 | HDAC3 (0.53) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL7624634 | 0.92 | HDAC3 (0.53) | HDAC3HDAC4HDAC1HDAC7HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240156982-A1 | METHOD OF FORMING PEPTIDE-COATED NANOPARTICLES | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 2024-05-16 | — | — | US | claimed |
| CN-112341493-B | Mitochondrial targeting melatonin based on triphenylphosphine modification and preparation method and application thereof | 重庆医药高等专科学校附属第一医院(重庆市职业病防治院 重庆市第六人民医院 重庆市中毒控制中心) | 2023-08-15 | — | — | CN | claimed |
| CN-112341493-A | Mitochondrial targeting melatonin modified based on triphenylphosphine and preparation method and application thereof | 重庆医药高等专科学校附属第一医院(重庆市职业病防治院重庆市第六人民医院重庆市中毒控制中心) | 2021-02-09 | — | — | CN | claimed |
| US-20250313552-A1 | NICOTINATE ESTERS AND THERAPEUTIC METHODS OF USE THEREOF | NEW FRONTIER BIO INC (US) | 2025-10-09 | — | — | US | disclosed |
| US-20250235805-A1 | LUBRICANT FOR FILTRATION CONTAINING ONIUM IONS | TOKUYAMA CORPORATION (JP) | 2025-07-24 | — | — | US | disclosed |
| US-20250215574-A1 | SEMICONDUCTOR TREATMENT LIQUID FOR REMOVING RUTHENIUM SILICIDE | TOKUYAMA CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| CN-119948603-A | Dry etching residue removing liquid | 株式会社德山 | 2025-05-06 | — | — | CN | disclosed |
| US-20250084309-A1 | SEMICONDUCTOR PROCESSING SOLUTION | TOKUYAMA CORPORATION (JP) | 2025-03-13 | — | — | US | disclosed |
| EP-4506982-A1 | LUBRICANT FOR FILTRATION CONTAINING ONIUM IONS | TOKUYAMA CORPORATION (JP) | 2025-02-12 | — | — | EP | disclosed |
| CN-119144005-A | Metal-based polymer nanoparticle antibacterial agent and preparation method and application thereof | 哈尔滨工业大学 | 2024-12-17 | — | — | CN | disclosed |
| CN-118974895-A | Filter lubricant containing onium ion | 株式会社德山 | 2024-11-15 | — | — | CN | disclosed |
| EP-0541407-A1 | Nitrogen containing bicyclic derivatives, method for their preparation and pharmaceutical compositions containing them | ADIR ET COMPAGNIE (FR) | 1993-05-12 | — | — | EP | disclosed |
| EP-0159784-B1 | CARBACYCLIN ANALOGUES | THE UPJOHN COMPANY (US) | 1989-06-07 | — | — | EP | disclosed |
| US-4683330-A | ANTICOAGULANTS, ANTIULCER AGENTS | THE UPJOHN COMPANY (US) | 1987-07-28 | — | — | US | disclosed |
| US-4338316-A | PROSTAGLANDIN F SERIES ANALOGUES | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1982-07-06 | — | — | US | disclosed |
| EP-0010360-B1 | PROSTANE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL COMPOSITIONS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1982-06-02 | — | — | EP | disclosed |
| US-4306095-A | USEABLE IN LUTEOLYSIS, INHIBITING BLOOD PLATELET AGGREGATION AND INHIBITING PRODUCTION OF GASTRIC ACID | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1981-12-15 | — | — | US | disclosed |
| US-4241215-A | FOR LUTEOLYSIS, INHIBITING BLOOD PLATELET AGGREGATION, AND INHIBITING SECRETION OF GASTRIC JUICES | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1980-12-23 | — | — | US | disclosed |
| EP-0010360-A1 | Prostane derivatives, processes for their preparation and their pharmaceutical compositions | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1980-04-30 | — | — | EP | disclosed |
| US-4071530-A | Pyrrolidones and process for preparing them | HOECHST AKTIENGESELLSCHAFT (DT) | 1978-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250313552-A1 | NICOTINATE ESTERS AND THERAPEUTIC METHODS OF USE THEREOF | NNT, NNMT, NAMPT | HDAC3 230/4885HDAC4 397/4885HDAC1 559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.